These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 31560620)
1. Challenges and Opportunities for Biomarker Validation. Hey SP; D'Andrea E; Jung EH; Tessema F; Luo J; Gyawali B; Kesselheim AS J Law Med Ethics; 2019 Sep; 47(3):357-361. PubMed ID: 31560620 [TBL] [Abstract][Full Text] [Related]
2. Current Practices and Challenges in Method Validation. Poitout F; Colangelo JL; Lavallée S; Aulbach AD; Piché MS; Ennulat D; Ameri M; Boone LI Toxicol Pathol; 2018 Oct; 46(7):847-856. PubMed ID: 30253718 [TBL] [Abstract][Full Text] [Related]
3. Conference report and review: current status of biomarkers potentially associated with prostate cancer outcomes. Flaig TW; Nordeen SK; Lucia MS; Harrison GS; Glodé LM J Urol; 2007 Apr; 177(4):1229-37. PubMed ID: 17382696 [TBL] [Abstract][Full Text] [Related]
4. The FDA/critical path initiative/Duke-Margolis center for health policy public workshop on analytical validation of assays for biomarker qualification: an update on the White Paper. Piccoli SP Bioanalysis; 2018 Jun; 10(12):893-896. PubMed ID: 29924636 [No Abstract] [Full Text] [Related]
5. Fit-for-purpose method development and validation for successful biomarker measurement. Lee JW; Devanarayan V; Barrett YC; Weiner R; Allinson J; Fountain S; Keller S; Weinryb I; Green M; Duan L; Rogers JA; Millham R; O'Brien PJ; Sailstad J; Khan M; Ray C; Wagner JA Pharm Res; 2006 Feb; 23(2):312-28. PubMed ID: 16397743 [TBL] [Abstract][Full Text] [Related]
6. What is a biomarker? Research investments and lack of clinical integration necessitate a review of biomarker terminology and validation schema. Ptolemy AS; Rifai N Scand J Clin Lab Invest Suppl; 2010; 242():6-14. PubMed ID: 20515269 [TBL] [Abstract][Full Text] [Related]
7. Translation of neurological biomarkers to clinically relevant platforms. Hayes RL; Robinson G; Muller U; Wang KK Methods Mol Biol; 2009; 566():303-13. PubMed ID: 20058180 [TBL] [Abstract][Full Text] [Related]
8. Biomarker Validation: Context and Complexities. McShane LM J Law Med Ethics; 2019 Sep; 47(3):388-392. PubMed ID: 31560629 [TBL] [Abstract][Full Text] [Related]
10. Biomarker method validation in anticancer drug development. Cummings J; Ward TH; Greystoke A; Ranson M; Dive C Br J Pharmacol; 2008 Feb; 153(4):646-56. PubMed ID: 17876307 [TBL] [Abstract][Full Text] [Related]
11. Validation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validation. Masucci GV; Cesano A; Hawtin R; Janetzki S; Zhang J; Kirsch I; Dobbin KK; Alvarez J; Robbins PB; Selvan SR; Streicher HZ; Butterfield LH; Thurin M J Immunother Cancer; 2016; 4():76. PubMed ID: 27895917 [TBL] [Abstract][Full Text] [Related]
12. Validation of biomarkers to predict response to immunotherapy in cancer: Volume II - clinical validation and regulatory considerations. Dobbin KK; Cesano A; Alvarez J; Hawtin R; Janetzki S; Kirsch I; Masucci GV; Robbins PB; Selvan SR; Streicher HZ; Zhang J; Butterfield LH; Thurin M J Immunother Cancer; 2016; 4():77. PubMed ID: 27891226 [TBL] [Abstract][Full Text] [Related]
13. The national biomarker development alliance: confronting the poor productivity of biomarker research and development. Poste G; Compton CC; Barker AD Expert Rev Mol Diagn; 2015 Feb; 15(2):211-8. PubMed ID: 25420639 [TBL] [Abstract][Full Text] [Related]
14. Building a roadmap to biomarker qualification: challenges and opportunities. Amur SG; Sanyal S; Chakravarty AG; Noone MH; Kaiser J; McCune S; Buckman-Garner SY Biomark Med; 2015; 9(11):1095-105. PubMed ID: 26526897 [TBL] [Abstract][Full Text] [Related]
15. The emerging science of quantitative imaging biomarkers terminology and definitions for scientific studies and regulatory submissions. Kessler LG; Barnhart HX; Buckler AJ; Choudhury KR; Kondratovich MV; Toledano A; Guimaraes AR; Filice R; Zhang Z; Sullivan DC; Stat Methods Med Res; 2015 Feb; 24(1):9-26. PubMed ID: 24919826 [TBL] [Abstract][Full Text] [Related]
16. Definitions and validation criteria for biomarkers and surrogate endpoints: development and testing of a quantitative hierarchical levels of evidence schema. Lassere MN; Johnson KR; Boers M; Tugwell P; Brooks P; Simon L; Strand V; Conaghan PG; Ostergaard M; Maksymowych WP; Landewe R; Bresnihan B; Tak PP; Wakefield R; Mease P; Bingham CO; Hughes M; Altman D; Buyse M; Galbraith S; Wells G J Rheumatol; 2007 Mar; 34(3):607-15. PubMed ID: 17343307 [TBL] [Abstract][Full Text] [Related]